Portal de Periódicos da CAPES

Non-invasive delivery of small interfering rubonucleic acid for reduction of Huntingtin expression in the brain is achieved using focused ultrasound to disrupt the blood-brain barrier

2013; Acoustical Society of America; Linguagem: Inglês

10.1121/1.4800368

1939-800X

Alison Burgess, Yuexi Huang, William Querbes, Dinah W.Y. Sah, Kullervo Hynynen,

Advanced Fluorescence Microscopy Techniques

Huntington's disease (HD) is caused by a mutation in the Huntingtin (Htt) gene which leads to neuronal dysfunction and cell death. Silencing of the Htt gene can halt or reverse the progression of the disease suggesting that RNA interference is an effective strategy for disease treatment. However, siRNA does not cross the blood-brain barrier (BBB) and therefore delivery to the brain is limited. Here, we demonstrate that focused ultrasound (FUS), combined with intravascular microbubble contrast agent, can locally and transiently disrupt the BBB and deliver siRNA into the brain. We disrupted the BBB in the right striatum of adult rats and delivered siRNA intravenously. 48 hrs following treatment, the right (treated) and left (control) striatum were dissected and analyzed for Htt mRNA levels. We observed a significant reduction in Htt expression in the right, treated striatum, in a dose dependent manner. Furthermore, reduction of Htt was positively correlated with the extent of BBB disruption. This study demonstrates that siRNA mediated reduction of Htt is feasible without the surgical intervention previously required for direct delivery to the brain. Non-invasive delivery of siRNA through the BBB would be a significant advantage for translating RNA interference therapy to HD patients.